In her lab, Elizabeth Shank, PhD, interprets the chemical language of bacteria with the goal of harnessing its power to potentially developing new antibiotics.

In her preliminary studies, PhD student Megan Honeywell has found that cells can trigger a cell death even when they do not have the p53 protein, the so-called “guardian of the genome.”

UMass Chan faculty in rheumatology, biochemistry & molecular biotechnology and cancer biology are being supported by endowments.

A large, double-blind, randomized controlled trial found that outpatients who received convalescent plasma within nine days of onset of COVID-19 symptoms were significantly less likely to be hospitalized than those who received placebo control plasma.

Read Pukkila-Worley, MD, is a physician-scientist researching how bacteria cause disease and how the immune system detects infection.

Raffi Van Aroian, PhD, studies intestinal parasitic nematodes, or worms, which can seriously impact children. To combat drug resistance, he and colleague Gary R. Ostroff, PhD, are working on a new type of treatment.

Jonathan Gerber, MD, discusses a therapy that has been around for at least a century and how it has helped in the COVID-19 pandemic.

Yang Wang, MD, PhD, leads a team of scientists working to discover and develop antibody-based medicines for infectious diseases and understand drug resistance in those medicines.

Worcester Business Journal readers have chosen the UMass Cancer Walk and Run as the best nonprofit fundraiser event in Central Massachusetts.

Hyundai Hope on Wheels has awarded Jason Shohet, MD, PhD, a second $300,000 Scholar Hope Grant to continue his research on neuroblastoma, a deadly cancer in children that affects the peripheral nervous system.